Nefopam topical cream - ScarX Therapeutics

Drug Profile

Nefopam topical cream - ScarX Therapeutics

Alternative Names: SCX-001

Latest Information Update: 04 Jul 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator ScarX Therapeutics
  • Class Antifibrotics; Non-opioid analgesics; Small molecules
  • Mechanism of Action Beta catenin inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Phase I Hypertrophic scars

Most Recent Events

  • 27 Jun 2017 ScarX Therapeutics completes enrolment in its phase I trial for Hypertrophic scars in Canada (NCT03036306)
  • 18 Aug 2016 Health Canada approves IND application for nefopam cream in Hypertrophic scars
  • 16 Feb 2016 Preclinical trials in Hypertrophic scars in Canada (Topical)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top